NCT00040053View on ClinicalTrials.gov

Ondansetron for the Treatment of Methamphetamine Dependence - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

February 29, 2004

Conditions
Amphetamine-Related Disorders
Interventions
DRUG

Ondansetron

Trial Locations (6)

50316

Powell Chemical Dependency Center, Des Moines

64108

University of Missouri - Kansas City, Kansas City

77225

University of Texas Health Science Center, Houston

91911

South Bay Treatment Center, Chula Vista

92627

Matrix Institute on Addictions, Costa Mesa

96813

John A. Burns School of Medicine, Honolulu

All Listed Sponsors
collaborator

University of Texas

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00040053 - Ondansetron for the Treatment of Methamphetamine Dependence - 1 | Biotech Hunter | Biotech Hunter